openPR Logo
Press release

Dermasensa celebrates 10 years of excellence, showcasing a decade of global success, innovation, and strategic growth

09-18-2024 09:10 PM CET | Sports

Press release from: ABNewswire

Dermasensa celebrates 10 years of excellence, showcasing

The 10th-anniversary celebration in Shanghai was a grand affair, reflecting on Dermasensa's impressive journey over the past decade.
Dermasensa [https://dermasensa.com/], the distinguished American skincare brand renowned for its advanced formulations and scientific approach, recently celebrated its 10th anniversary with a landmark event that highlighted a decade of global success, innovation, and strategic growth. This momentous occasion not only marked a significant milestone for the brand but also set the stage for exciting new developments and partnerships.

Image: https://www.abnewswire.com/uploads/ed5446e317b0d9b69d786236b43222eb.png

A Landmark Celebration

The 10th-anniversary celebration in Shanghai was a grand affair, reflecting on Dermasensa's impressive journey over the past decade. Founder and CEO Dr. Mark Miller delivered an inspiring opening address that underscored the brand's commitment to advancing skincare science and its dedication to delivering cutting-edge solutions. Dr. Miller's speech was a testament to Dermasensa's continuous pursuit of excellence and its impact on the global skincare market.

Strategic Partnership with Lubrizol

A major highlight of the event was the announcement of Dermasensa's renewed strategic partnership with Lubrizol, a global leader in advanced peptides technologies. The partnership was formalized with the signing of a Memorandum of Understanding (MOU) between Dr. Mark Miller and Bernardo Medeiros, VP of Lubrizol's Beauty & Life Sciences division. Lubrizol's Lipotec subsidiary, known for its pioneering peptide technologies, will continue to play a crucial role in enhancing Dermasensa's product efficacy. This strategic alliance is set to drive innovation and further solidify Dermasensa's position as a leader in skincare technology.

Key Success and Important Innovation Announcements

The celebration also showcased several key innovations that highlight Dermasensa's commitment to scientific excellence and product development:

- Vitamin K Dark Circle Eye Serum: This flagship product has been enhanced with a groundbreaking evaluation method developed in collaboration with Dr. Jiang Wencai of Shanghai Skin Disease Hospital. The new approach provides a more accurate assessment of dark circle improvement, reflecting Dermasensa's dedication to advancing skincare efficacy and precision.

- UP Ultra Peptide Lifting Serum: a standout in Dermasensa's product lineup, has been upgraded to its 2.0 version. This advanced formulation features the latest Uplevity E-lift peptide and 10% Argireline Amplified, delivering exceptional anti-aging & lifting benefits and demonstrating Dermasensa's leadership in peptide technology. The serum's proven uplifting effects and clinical trial results underscore its effectiveness in combating the visible signs of aging.

- 2025 Innovation Strategy: Dermasensa unveiled its ambitious 2025 strategy, which focuses on pioneering solutions for skin tone management and UV protection. This forward-looking initiative includes innovative brightening solutions designed to address diverse skincare needs and set new standards in skincare technology.

Brand Ambassador Sadie Calvano's Heartfelt Message

Adding a personal touch to the celebration, brand ambassador Sadie Calvano sent a heartfelt video message to commemorate Dermasensa's 10th anniversary. Sadie is known for her movie and television roles, including starring as April in the acclaimed series "Why Women Kill" and Violet in the situation comedy "Mom." Sadie expressed her enthusiasm and pride in being associated with the brand. Although she was unable to attend the event in person due to her filming commitments, her video resonated with the audience, highlighting her long-standing relationship with Dermasensa and her genuine appreciation for the brand's products. Sadie's message not only celebrated Dermasensa's achievements but also reinforced the strong connection between the brand and its ambassadors.

Website Relaunch

In conjunction with these exciting announcements, Dermasensa revealed plans to relaunch its website www.dermasensa.com [http://www.dermasensa.com/]. The redesigned site will offer an enhanced user experience, featuring improved navigation and access to the latest product information. The relaunch aims to provide customers with a more seamless and engaging online shopping experience, reflecting the brand's commitment to innovation and customer satisfaction.

Gratitude and Future Outlook

The event concluded with a heartfelt expression of gratitude to all attendees, including leading beauty influencers, distributors, and esteemed medical professionals. Dr. Mark Miller extended his sincere thanks for their unwavering support and partnership throughout the years. The celebration was not only a reflection on Dermasensa's impressive achievements but also a look forward to the future, filled with continued growth and innovation.

As Dermasensa embarks on the next decade, the brand remains steadfast in its mission to advance skincare science and deliver groundbreaking solutions that meet the evolving needs of its global customer base. The event served as a poignant reminder of Dermasensa's dedication to excellence and its vision for a brighter, more innovative future in skincare.

Tour of the New In-Vivo Lab

Following the event, guests were given an exclusive tour of Lubrizol's newly inaugurated In-Vivo Lab. This state-of-the-art facility, equipped with millions of dollars' worth of advanced instruments, is designed to enhance the accuracy and efficiency of human efficacy evaluations. The lab's cutting-edge technology will significantly advance Dermasensa's ability to validate and improve product performance scientifically. The tour highlighted Dermasensa's commitment to investing in research and development and underscored the brand's dedication to pushing the boundaries of skincare technology.

Media Contact
Company Name: Dermasensa Laboratories, Inc.
Contact Person: Shelby Miller
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=dermasensa-celebrates-10-years-of-excellence-showcasing-a-decade-of-global-success-innovation-and-strategic-growth]
Phone: +17029483055
City: Henderson
State: NV
Country: United States
Website: https://dermasensa.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dermasensa celebrates 10 years of excellence, showcasing a decade of global success, innovation, and strategic growth here

News-ID: 3659990 • Views:

More Releases from ABNewswire

Dry Eye Disease Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Palatin Technologies, Novaliq, mc2 therapeutics
Dry Eye Disease Market Growth to Accelerate in Forecast Period (2024-2034), Delv …
The Key Dry Eye Disease Companies in the market include - Palatin Technologies, Novaliq, mc2 therapeutics, and others. The Dry Eye Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Dry Eye Disease pipeline products will significantly revolutionize the Dry Eye Disease market dynamics. DelveInsight's "Dry Eye Disease Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding
Atopic Dermatitis Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight | Kymab, BiomX, LEO Pharma, GlaxoSmithKline, Arjil Pharma, SCM Lifescience, Sun Pharma, Brickell Bio
Atopic Dermatitis Market Forecasted to Surge in Coming Years, 2024-2034 Analysis …
The Key Atopic Dermatitis Companies in the market include - Kymab, BiomX, LEO Pharma, GlaxoSmithKline, Arjil Pharmaceuticals, SCM Lifescience, Sun Pharmaceutical Industries Limited, Brickell Biotech Inc,, AstraZeneca, Kyowa Kirin, UCB Biopharma, Arcutis Biotherapeutics, Vanda Pharmaceuticals, Kyowa Kirin, Sanofi, KeyMed Biosciences, Asana BioSciences, Bristol-Myers Squibb, RAPT Therapeutics, Allakos, Novartis, BioMimetix, Shanghai Hengrui Pharmaceutical Co, Connect Biopharma, Pfizer, and others. DelveInsight's "Atopic Dermatitis Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth
Affordable Roofing Systems: Tampa Roofing Company Prioritizes Emergency Roof Repairs Post-Hurricane Milton
Affordable Roofing Systems: Tampa Roofing Company Prioritizes Emergency Roof Rep …
Tampa, FL - In the wake of Hurricane Milton, which left over 500,000 customers without power in Hillsborough County alone and caused widespread roof damage in areas like St. Petersburg and Sarasota, Affordable Roofing Systems, Inc. [https://www.affordableroofingflorida.com/], a Tampa-based roofing contractor, is responding to the growing demand for emergency roof repairs. With more than 25 years of experience in Florida's weather challenges, the company has mobilized its team to provide
Cystinosis Market Expected to Experience Major Growth by 2034, According to DelveInsight | Horizon Pharma, Chiesi Farmaceutici, Recordati S.p.A, Nacuity Pharma, Nacuity Pharma, Avrobio
Cystinosis Market Expected to Experience Major Growth by 2034, According to Delv …
The Key Cystinosis Companies in the market include - Horizon Pharmaceutical/Chiesi Farmaceutici, Recordati S.p.A, Nacuity Pharmaceuticals, Inc., Nacuity Pharmaceuticals, Avrobio, and others. The Cystinosis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Cystinosis pipeline products will significantly revolutionize the Cystinosis market dynamics. DelveInsight's "Cystinosis Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Cystinosis, historical

All 5 Releases